|
BioScreening - organic compounds for screening
Drug Discovery SoftwareCLC bio to collaborate with Microsoft on integrating life science technology - Boston, USA — April 29, 2008 — Today at the Bio-IT World Conference & Expo in Boston, USA, CLC bio announced collaboration with Microsoft Corp. on integrating CLC bio’s extensive bioinformatics solutions with Microsoft’s software platform, for the benefit of companies, corporations, and institutions in the biotech, pharmaceutical, and life science sectors. CLC bio has [...]
Evotec Expands Collaboration with InterMune - Hamburg, Germany | Oxford, UK- Evotec AG (Frankfurt Stock Exchange: EVT) today announced that InterMune, Inc., has signed a second drug discovery contract with Evotec.
Evotec will support InterMune’s research efforts using their medicinal chemistry know-how. In addition, they will utilize their expertise and technologies in computational chemistry, protein production, X-Ray crystallography and ADMET to further [...]
CLC bio provides bioinformatics solution for vaccine target development to ACE BioSciences - Odense & Aarhus, Denmark — December 18, 2007 — ACE BioSciences, an emerging pharmaceutical company focused on developing novel protein-based vaccines and antibodies to address infectious diseases, and CLC bio, the world’s leading bioinformatics solutions provider, today announced a collaborative bioinformatics agreement.
Dr. Ingelise Saunders, Chief Executive Officer at ACE BioSciences [...]
CLC bio helps increase productivity with new integrable database solution - Aarhus, Denmark — November 29th, 2007 — CLC bio, the world’s leading bioinformatics solution provider, today announced the release of CLC Bioinformatics Database. This powerful and versatile database solution enables research organizations, from small university departments and clinical labs to large biotech and pharmaceutical companies, to maximize their potential, through [...]
New Database Screening Criteria Improves Identification Of Anticancer Drugs - Scientists in Indiana and Michigan have developed a better way of mining a vast computerized database for chemical nuggets that could become tomorrow’s cancer medications.
The new “data mining” method pinpoints chemical structures with drug-like activity. It could speed the identification and development of new, more effective drugs against breast, prostate, lung and other cancers.
Computers have [...]
Upstream Biosciences Launches Chemoinformatics Program to Extend Its Drug Discovery Capabilities - Upstream Biosciences Inc. (OTCBB: UPBS) today announced it is establishing a Chemoinformatics Program to extend its drug discovery efforts into additional disease areas. Upstream’s Chemoinformatics Program combines artificial intelligence, advanced computational methods and chemical diversity techniques that will be applied to the company’s proprietary drug scaffolds and compound library. This effort will initially build on [...]
Reducing the ‘what ifs’ in drug discovery - With emergence of specialised software applications, drug discovery has become a highly cost-competitive area for Indian pharma companies. Nagesh Joshi examines the use of specialised software applications in drug discovery
Drug discovery was the main aim of any pharma company, prior to the advent [...]
BIO-Europe 2007 to Offer Free Access to DMS Biotech Industry Database - Carlsbad, CA, and Washington D.C., Sept. 27, 2007 – EBD Group and the Biotechnology Industry Organization (BIO) today announced a collaboration with DMS Data Systems, a provider of online life sciences industry data, to provide BIO-Europe 2007 attendees with access to the DMS Data Center, which contains information on specific diseases, technologies and other market-specific [...]
CLC bio solves bioinformatics data management challenges with release of database solution - Aarhus, Denmark — October 12th, 2007 — CLC bio, the world’s leading bioinformatics solution provider, today announced a November release of CLC Bioinformatics Database. This powerful and versatile database solution - currently in beta-testing - enables users of CLC bio’s DNA, RNA, and protein sequence analysis software to store and work on their sequence data [...]
Spellex releases Spellex Biotech v.2007, the newest upgrade of the world’s first Bioscience spell checking software. - TAMPA, FL — Spellex Corporation announces the new release of the 2007 version of their popular bioscience spelling software for Microsoft and other programs. The new release includes more than 200,000 specialty words from the bioscience industry and new spelling engine enhancements.
Benefits:Â Â The Spellex Biotech spelling dictionary allows users to save time and increase [...]
Unigen Pharmaceuticals reaps the rewards of a software product that enables CASE, better data management, and reporting - Toronto, Canada (July 26, 2007) - Leading natural product research and development company and proprietary ingredients supplier, Unigen Pharmaceuticals, found a solution to the challenges of managing multiple analytical techniques and data formats to effectively carry out structure elucidation for lead compounds. Implementing an innovative software product, ACD/Structure Elucidator, eases the burden of structure elucidation [...]
Pan-South American biological database project under way - Aarhus Denmark, June 27, 2007 — The project of creating a South American biological database - with the official name Patrimonio Genómico y Saberes Locales (PGSL) which roughly translates to “Genomic Heritage and Local Wisdom” - manifested itself with a recent inaugural meeting in Ecuador, where universities and government agencies from [...]
CLC bio funds further acceleration of bioinformatics product development - Aarhus, Denmark, July 3, 2007 — Today CLC bio, the world’s leading bioinformatics solution provider, announced that the company has entered an agreement, which ensures a significant amount of additional financing from local Danish private investors.
The group of private investors behind CLC bio has a capital base of more than 200 [...]
CLC bio’s solutions fully compatible with Windows Vista and upcoming Mac OS X Leopard - Aarhus, Denmark, July 5, 2007 — CLC bio has once again proven their commitment to delivering true cross-platform software and regular updates with new and improved features. With last week’s major release of their software workbenches, CLC bio now fully supports Windows Vista, as well as the upcoming Mac OS X [...]
CLC bio releases Molecular Diagnostics Solution - Aarhus, Denmark, July 12, 2007 — CLC bio just released a molecular diagnostics solution for Multilocus Sequence Typing (MLST). MLST is a portable and precise state-of-the-art technique for typing bacteria and yeast isolates. The development of this new module was motivated by usability studies showing that a typical current-day MLST workflow [...]
Related Fragment Screening: Swift and Easy Elucidation of Drug Metabolites - Software assigns, interprets and organizes LC/MS data, making it easier to visualize structural relationships between parent drugs and metabolites. Related fragment screening will be highlighted at an ACD/Labs MS Seminar (register) held in advance of the 55th ASMS Conference on Mass Spectrometry on Sunday, June 3rd, from 1:30-4:30 p.m. in Indianapolis, IN.
Toronto, Canada (PRWEB) May [...]
Related Fragment Screening: Swift and Easy Elucidation of Drug Metabolites - Software assigns, interprets and organizes LC/MS data, making it easier to visualize structural relationships between parent drugs and metabolites. Related fragment screening will be highlighted at an ACD/Labs MS Seminar (register) held in advance of the 55th ASMS Conference on Mass Spectrometry on Sunday, June 3rd, from 1:30-4:30 p.m. in Indianapolis, IN.
Toronto, Canada (PRWEB) May [...]
CLC bio joins $2.5M research project on HIV, bird flu, and other RNA-based diseases - Aarhus Denmark, April 30, 2007 — CLC bio, the IT University of Copenhagen, and the Department of Molecular Biology at the interdisciplinary nano science centre (iNANO) of University of Aarhus are proud to announce that the Danish Council for Strategic Research has approved to fund the ambitious and ground-breaking research project PC Mini Grids for [...]
4SC AG has Received Clinical Trial Approval by Authorities and has Started the Clinical Phase IIa Study - PLANEGG-MARTINSRIED, Germany, December 4/PRNewswire/ — The drug discovery and development company 4SC AG (Frankfurt, Prime standard: VSC) announced today the beginning of a clinical phase IIa - study of drug candidate SC12267 for the treatment of patients with rheumatoid arthritis. 4SC AG received the necessary approval by the Federal Institute for Drugs and Medical Devices, [...]
NCE Discovery and DARA BioSciences Join Forces to Develop New Therapies - CAMBRIDGE, England, Dec. 6, 2006–NCE Discovery Ltd (NCED), the specialist medicinal chemistry and drug design service provider, has entered into an agreement with US-based DARA BioSciences, Inc. to work together on the development of new drug target molecules.
DARA BioSciences discovers and develops small molecule treatments for metabolic and CNS diseases and, under the terms of [...]
Sponsored Links
|
|
